CL vs VVOS · P/E 34, rev $20.38B vs rev $15.0M
Colgate-Palmolive Company (CL) versus Vivos Therapeutics Inc (VVOS) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Vivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported VVOS revenue for 2024-12-31 was $15.0M. Net income was -$11.1M. Revenue was up 8.9% from 2023-12-31 to 2024-12-31. VVOS currently screens at market cap $7.1M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. VVOS currently screens at market cap $7.1M.
Not investment advice. Open the CL and VVOS stock pages for the full models.
Not investment advice.